Page last updated: 2024-08-23

etoposide and Dermatitis, Radiation-Induced

etoposide has been researched along with Dermatitis, Radiation-Induced in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, GJ; Crane, CH; Das, P; Feig, BW; Krishnan, S; Minsky, BD; Rashid, A; Skibber, JM; Voong, KR; Wolff, RA; Yao, JC	1
Ainslie, J; Hamilton, C; Harvey, J; Keller, J; Macintosh, J; Poulsen, M; Rischin, D; Tripcony, L; Walpole, E	1

Trials

1 trial(s) available for etoposide and Dermatitis, Radiation-Induced

Article	Year
Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study. International journal of radiation oncology, biology, physics, 2001, Sep-01, Volume: 51, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Fever; Follow-Up Studies; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Quality of Life; Radiodermatitis; Radiotherapy Dosage; Skin Neoplasms	2001

Article

Year

Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study.

International journal of radiation oncology, biology, physics, 2001, Sep-01, Volume: 51, Issue:1

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Fever; Follow-Up Studies; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Quality of Life; Radiodermatitis; Radiotherapy Dosage; Skin Neoplasms

2001

Other Studies

1 other study(ies) available for etoposide and Dermatitis, Radiation-Induced

Article	Year
Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal. American journal of clinical oncology, 2017, Volume: 40, Issue:6 Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Capecitabine; Carboplatin; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Consolidation Chemotherapy; Diarrhea; Digestive System Surgical Procedures; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Induction Chemotherapy; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Pelvis; Radiation Injuries; Radiodermatitis; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Rectum; Retrospective Studies; Survival Rate; Tumor Burden	2017

Article

Year

Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.

American journal of clinical oncology, 2017, Volume: 40, Issue:6

Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Capecitabine; Carboplatin; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Consolidation Chemotherapy; Diarrhea; Digestive System Surgical Procedures; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Induction Chemotherapy; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Pelvis; Radiation Injuries; Radiodermatitis; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Rectum; Retrospective Studies; Survival Rate; Tumor Burden

2017